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ABSTRACT
Introduction: Human papillomavirus (HPV)
alone is thought to cause *610,000 cases of
cancer per year, and is the dominant aetiologi-
cal agent for ano-genital (esp. cervical) and head
and neck cancers (esp. oropharyngeal). Merkel
cell polyomavirus (MCV) is a more recently
discovered virus which causes Merkel cell car-
cinoma, a rare but highly aggressive skin
malignancy.
Methods: We explored the available published
evidence to see if transmission of live HPV or
MCV virus in smoke generated by laser or dia-
thermy was feasible, and would pose an infec-
tion risk. Long-term infection with such
carcinogenic viruses would then pose an
increased risk for the development of virus-in-
duced cancers in medical personnel.
Results: The morphological structures of both
HPV and MCV are very similar, and the size,
external capsids and genomic structures show
striking similarity. Both viruses have a non-en-
veloped external protein capsid consisting of 72
capsomeres, and a double-stranded DNA core.
Sizes of both viruses range from 50 to 60 nm.
There are now recent data demonstrating live
and infectious HPV in smoke, and that these
viruses can be used to infect cells in vitro. Fur-
ther, anecdotal reports of virus transmission
leading to disease causation in the production
of respiratory airway viral warts (benign dis-
ease), and, finally, reports of HPV-induced
oropharyngeal carcinoma (malignant disease)
in two gynaecological surgeons as an occupa-
tional health hazard have been published
recently.
Conclusion: There is now sufficient evidence to
support the hypotheses that live infectious car-
cinogenic viruses can be transmitted via smoke
generated from surgical procedures, and, in rare
instances, actually cause significant disease.
Protective measures such as smoke extraction
and airway protection should be instituted for
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all healthcare personnel, particularly those with
multiple repeated exposures such as gynaeco-
logical surgeons.
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INTRODUCTION
Virus-induced cancers of the skin and mucosa
are important causes of total cancer in the
world. For instance, human papillomavirus
(HPV) is thought to account for *4.8% of total
world cancers each year, and these cancers
include ano-genital cancers, and head and neck
cancers [5]. In 2006, the WHO classified HPV as
a Class I carcinogen. This was in recognition of
the worldwide importance of HPV in causing
several different types of cancers in different
anatomical locations and systems. Alpha group
HPV (which tend to infect the genital skin and
mucosae) are the dominant group of HPV
involved in the ano-genital cancers, and head
and neck cancer epidemics currently seen
worldwide.
Mutations in skin cell DNA due to ionising
UV radiation is by far the most important risk
factor for development of skin cancers. Other
important risk factors for squamous cell carci-
noma (SCC) of skin are white skin, increased
age, male sex, and decreased immune status
[14]. The link between HPV and SCC skin was
initially noted in a specific cohort of patients
with epidermodysplasia verruciformis (EV). EV
is a rare genetic disorder, most commonly
autosomal recessive in its Mendelian inheri-
tance, characterised by decreased cell-mediated
immunity and infection by beta group HPV
which leads to widespread plaques and papil-
lomas/wart-like lesions, and a high risk of SCC
of skin. Beta group HPV 5 and 8 are the types
most commonly associated with SCC of skin in
these patients [8]. The lifetime risk of develop-
ing skin SCC in the USA is thought to range
from 7% to 11%, and is estimated to be even
higher in Australia [3]. Accurate data on the
incidence of skin SCC in the UK is not readily
available due to inefficiencies in data collection
and the cancer registry system, but is thought to
also be increasing [10].
Merkel cell carcinoma (MCC) is a rare neu-
roendocrine tumour of the skin with highly
aggressive behaviour and increasing incidence,
and its viral causation has recently been eluci-
dated. MCC has high metastatic potential
regardless of the size of the primary tumour and
a 5 year disease associated mortality of 46%
[12]. MCV was first described in causal associa-
tion with Merkel cell carcinoma in 2008 by the
group led by Patrick Moore at the University of
Pittsburgh [4]. Since then, others have con-
firmed their findings, that infection of suscep-
tible cells in the skin (possibly Merkel cells or
dermal stem cells) can lead to viral DNA inte-
gration with subsequent clonal replication of
infected cells, and this leads to tumour
formation.
The annual estimated age standardised inci-
dence rate of MCC in the UK is between 0.1 and
0.2 per 100,000 (1999–2008) and is thought to
be increasing [9] (http://www.ncin.org.uk/
publications/data_briefings/rareskincancer).
In the East of England, the age standardised
incidence rates for MCC in males and females
are 0.19 and 0.24 per 100 000 person-years,
respectively. The total age standardised inci-
dence rate was 0.21 per 100 000 person-years
and represents a threefold increase in this
region from 2004 to 2013 [9]. The main risk
factors for MCC development are high UV
exposure, white race (the significance of mela-
nin protection appears important), elderly age
(median age at diagnosis is 76.2 years for
women, and 73.6 years for men), and
immunosuppression.
The prevalence of MCV in the community is
extremely common, with 80% of healthy North
American adult (blood donors) found to be
seropositive for past MCV exposure [16]. Also
consistent with this, MCV was detected in 80%
of skin swabs from healthy volunteers, and this
suggests that it may be a common inhabitant of
human skin microflora [6]. The pathogenesis of
MCC is clearly not a simple one. Infection with
MCV is clearly not sufficient to cause MCC, as
demonstrated by the markedly differing inci-
dence with prevalence rates in the population.
Therefore, additional cellular and molecular
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events must occur, probably with viral integra-
tion into the cellular genome and loss of
immunosurveillance before tumour pathogen-
esis finally occurs. In this regard, MCV encodes
a large T tumour antigen (LT) and a small
tumour antigen (sT) which play a role in
pathogenesis by targeting several tumour sup-
pressor genes [2].
In this article, we have sought to understand
if laser or diathermy smoke is able to transmit
virus from skin or mucosa to attending medical
personnel, and whether virus transmitted in
this way is able to infect and cause cancer in the
longer term. We directly review the morpho-
logical structure of HPV and MCV, and searched
for published evidence whether these viruses
are able to persist in smoke and remain viable.
We then looked for reports of benign and
malignant tumours associated with chronic
infection with these viruses.
METHODS
We undertook a literature search through
PubMed Central using different combinations of
the words ‘‘HPV, human papillomavirus, Merkel
cell polyomavirus, MCV, lasers, laser smoke,
diathermy, diathermy smoke, plume(s)’’. We
have preferentially included publications since
2000 to ensure more up-to-date data unless the
article found was highly relevant for smoke or
diathermy. Exclusion criteria included non-E-
nglish and non-German articles. Further
cross-referencing from the reference lists of these
papers and the end results of the search for laser
and diathermy smoke publications involving
HPV and MCV are discussed below. This article
does not contain any new studies with human or
animal subjects performed by any of the authors.
RESULTS AND DISCUSSION
Structural Analysis
We have summarised below the useful mor-
phological comparisons between HPV and MCV
in Table 1.
Both MCV (family Polyomaviridae) and HPV
(family Papillomaviridae) were classified within
the family Papovaviridae (now obsolete)
because of their structural similarities. Both
viruses consist of a double-stranded (ds) DNA
core, surrounded by non-enveloped capsid.
The MCV icosahedral capsid is formed of 72
capsomeres, each consisting of 5 VP1 proteins
associating with a VP2 and a VP3 protein. The
DS-DNS genome is approximately 5.4 kb in
length.
The HPV icosahedral capsid is also formed of
72 capsomeres, which consist of 5 L1 proteins
encasing an L2 core each. The DS-DNA genome
is approximately 8 kb in length.
It is clear that HPV and MCV are structurally
very similar. EM images of both viruses are
essentially identical.
Aerosolization of Viruses in Laser
or Diathermy Smoke
Although published data on MCV in electro-
cautery or laser smoke are not available,
numerous published studies looking at HPV (a
virus very similar in structure and size) in
exactly this situation, are available. A previous
study for HPV DNA detection in electrocautery
smoke yielded positive identification of intact
HPV virions, and demonstrated infectivity of
these virions [15].
Further, there are anecdotal reports of HPV
transmission from patient to surgeon via laser
smoke. In one case, a surgeon contracted
laryngeal papillomatosis after treating anogeni-
tal condylomata by ablation with laser [11]. The
44-year-old surgeon stated categorically that
there were no other (i.e. sexually transmitted)
methods in which he could have contacted HPV
types 6 and 11 apart from the operating theatre.
In another case (published in German), a 28-
year-old gynaecological theatre nurse who
assisted in laser ablation of anogenital condy-
lomata developed laryngeal papillomatosis [1].
Her case was thoroughly investigated by a
prestigious virology institute in Germany and
hers was deemed to be a case of occupational
disease.
Dermatol Ther (Heidelb) (2017) 7:249–254 251
There has also been a study to isolate bovine
papillomavirus (BPV) from laser smoke in con-
trolled laboratory conditions, and the authors
succeeded in demonstrating infectivity by
inoculation of the extracted virions onto bovine
skin and mucosa, with subsequent growth of
papillomas [7].
Papillomaviridae and Polyomaviridae are
structurally very similar and share very similar
morphology, and therefore data from one sug-
gest that it could possibly be extrapolated to the
other.
Finally, there are now recent anecdotal
reports of HPV ? oropharyngeal carcinoma
occurring in gynaecological surgeons who have
performed thousands of cases of laser surgery.
These two cases in surgeons appear to confirm
that the risk of contracting HPV from laser
smoke is a real one, and, what is more con-
cerning, the transmission of high-risk HPV
appears to be responsible for these cases of head
and neck carcinoma [13]. One of us, (R.A.F.C.),
a senior gynaecological surgeon, has been a
proponent of smoke extraction for CO2 lasering
of the cervix since the 1990s. Furthermore, the
adoption of large loop diathermy excision of
the transformation zone by UK gynaecological
oncology centres as the main treatment
modality (as part of a single see and treat strat-
egy) for the cervical screening programme has
been useful, as it generates much less smoke
compared to the CO2 laser.
Limitations of Study and Learning Points
The available published literature on viruses in
smoke is small, and the case reports of
virus-associated tumours are few and anecdo-
tal. There is no direct evidence in terms of
long-term follow-up studies. However, despite
the circumstantial evidence, there is now suf-
ficient evidence to emphasise that all health-
care personnel should be taking all available
safety precautions in their daily work in seeing
and treating patients, as the consequences of
developing a malignancy is potentially
life-threatening. The learning points are sum-
marised below:
• Human papillomavirus (HPV) and Merkel
cell polyomavirus (MCV) are viruses that
cause cancers of the skin and mucosae.
Table 1 Structural comparisons between human papillomavirus and Merkel cell polyomavirus
Virus HPV (human papillomavirus) MCV (human
polyomavirus 5)
Family (prev. both in Papovaviridae—obsolete
term)
Papillomaviridae Polyomaviridae
Group 1 (ds-DNA) 1 (ds-DNA)
Genera Alpha-, Beta-, Gamma-, Mu-,
Nu-Papillomaviridae
Polyomaviridae
Size (nanometers) *55–60 *50–60
Genome length (kb) *8 *5.4
Genome structure Circular double-stranded DNA Circular double-stranded
DNA
Envelope No No
Icosahedral capsid exterior Yes Yes
Capsomeres 72 72
Capsomere structure 5L1 with 1L2 5VP1 with 1VP2 and 1VP3
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• These cancers appear to increasing steadily
in frequency across the world.
• Healthcare personnel are exposed to smoke
from laser or diathermy plumes when treat-
ing patients.
• Viable infectious viruses have been isolated
from smoke.
• Case reports of both benign and malignant
tumours occurring in healthcare personnel
with no other risk factors have now been
reported.
CONCLUSIONS
The available evidence appears to suggest that
there is a possibility that transmission of viruses
such as HPV or MCV from patient to surgeon or
other theatre staff is a real risk, particularly for
repeated laser operations on high-risk sites such
as the anogenital area; therefore, it remains
prudent to recommend that all available
options, such as efficient smoke extraction sys-
tems, respirator filtration masks, surgical face
masks with particulate filtration, etc., to min-
imise or prevent surgeon exposure to laser or
diathermy smoke should be utilised. Evidence
of the development of subsequent malignancies
in these gynaecological surgeons is now avail-
able. The multifactorial oncogenesis process
which leads to malignancy must be fulfilled for
cancer to develop, and this is a reason for pos-
itivity, because it ensures that the actual risk of
developing cancer is low.
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